Orb Biotronics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-01-2025
- Paid Up Capital ₹ 1.00 M
as on 08-01-2025
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 M
as on 08-01-2025
- Revenue -61.33%
(FY 2022)
- Profit -34.74%
(FY 2022)
- Ebitda -565.77%
(FY 2022)
- Net Worth -2.38%
(FY 2022)
- Total Assets -9.98%
(FY 2022)
About Orb Biotronics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.14 M.
Basanti Pramanik, Sujoy Pramanik, and Shib Pramanik serve as directors at the Company.
- CIN/LLPIN
U51909WB2002PTC095376
- Company No.
095376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2002
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Orb Biotronics Private Limited offer?
Orb Biotronics Private Limited offers a wide range of products and services, including Forceps & Graspers, Electrosurgical Unit, Surgical Scalpels, Insufflators, Laparoscopic Instruments, Medical Laboratory Instruments, Hematology Analyzers.
Who are the key members and board of directors at Orb Biotronics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Basanti Pramanik  | Director | 23-Mar-2009 | Current |
| Sujoy Pramanik | Director | 01-Sep-2014 | Current |
| Shib Pramanik | Director | 15-Nov-2002 | Current |
Financial Performance of Orb Biotronics.
Orb Biotronics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 61.33% decrease. The company also saw a substantial fall in profitability, with a 34.74% decrease in profit. The company's net worth dipped by a decrease of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orb Biotronics?
In 2020, Orb Biotronics had a promoter holding of 89.00% and a public holding of 11.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.14 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2014 | Bank Of India | ₹1.14 M | Open |
How Many Employees Work at Orb Biotronics?
Unlock and access historical data on people associated with Orb Biotronics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orb Biotronics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orb Biotronics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
